Delivery Order SPE2DB20D7059-SPE2DB25FQDR5

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,689.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ROTATEQ vaccine, a 2ml vaccine product, and is a firm fixed-price delivery order with a completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $8,223.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the ROTATEQ vaccine, a 2ml dose, with an ultimate completion date of April 29, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,147.40 Firm Fixed Price Delivery Order is for the supply of the ROTATEQ VACCINE 2ML product, with a period of performance through December 12, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.00 firm fixed-price delivery order is for the supply of the ROTATEQ vaccine, a rotavirus vaccine, to support military healthcare programs. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the ROTATEQ vaccine in 2 milliliter volumes. The firm-fixed-price Delivery Order is valued at $2,131.20 and has a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,885.60, is for the delivery of the ROTATEQ vaccine, a 2-milliliter dosage. The contract has an ultimate completion date of January 15, 2025. This contract is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,033.24, is for the delivery of the ROTATEQ vaccine in 2 milliliter doses. It is a firm fixed price delivery order contract with a completion date of January 15, 2025. The contract was not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.58 firm fixed-price delivery order is for the ROTATEQ vaccine, a vaccine for the prevention of rotavirus gastroenteritis in children. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,844.86 firm fixed-price contract is for the supply of the ROTATEQ vaccine, a pediatric rotavirus vaccine, to support military healthcare programs. The contract has a completion date of February 14, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is a delivery order valued at $2,428.01 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTATEQ vaccine, a 2ml vaccine product, with a completion date of April 4, 2025. The contract utilizes a firm fixed-price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQDR5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,853.05, is for the supply of ROTATEQ vaccine (2ML) and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This award is not designated as a set-aside contract.

Generated 7/8/25, 2:21 PM